Early apoptosis in human myocardial infarcts

被引:130
作者
Veinot, JP
Gattinger, DA
Fliss, H
机构
[1] UNIV OTTAWA,FAC MED,DEPT PHYSIOL,OTTAWA,ON K1H 8M5,CANADA
[2] UNIV OTTAWA,INST HEART,DEPT LAB MED,OTTAWA CIVIC HOSP,OTTAWA,ON K1N 6N5,CANADA
基金
英国医学研究理事会;
关键词
apoptosis; human myocardium; infarct; necrosis; DNA fragmentation;
D O I
10.1016/S0046-8177(97)90039-3
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Myocardial apoptosis has previously been observed in human acute myocardial infarcts. We examined the time of appearance and extent of apoptosis in human acute myocardial infarcts, and compared these with necrotic cell death. Because nuclear internucleosomal DNA fragmentation is a hallmark of apoptosis, autopsied tissue from cases of acute myocardial infarct of varying histological ages was subjected to two tests that identify such fragmentation: in situ end-labeling (ISEL) and DNA electrophoresis on agarose gels. Both tests showed widespread apoptosis in infarcts only a few hours in age before the appearance of coagulative necrosis. No apoptosis was detected in normal myocardium. ISEL in recent infarcts was visible primarily in myocytes containing contraction bands, which occur pre dominantly in regions of reperfused myocardium. During the next 1 to 2 days, ISEL remained extensive but increasingly appeared in cells with morphological features of coagulative necrosis, representative of nonreperfused myocardium. In older infarcts, the incidence of apoptosis declined in myocytes, but increased in invading inflammatory cells. These data suggest that apoptosis is the early and predominant form of cell death in infarcted human myocardium, and that its appearance is accelerated in reperfused myocardium. Therapies directed at early rescue of apoptotic myocytes may, therefore, prove valuable. Copyright (C) 1997 by W.B. Saunders Company.
引用
收藏
页码:485 / 492
页数:8
相关论文
共 40 条
[1]   CARDIOPROTECTIVE EFFECT OF INSULIN-LIKE GROWTH-FACTOR-I IN MYOCARDIAL-ISCHEMIA FOLLOWED BY REPERFUSION [J].
BUERKE, M ;
MUROHARA, T ;
SKURK, C ;
NUSS, C ;
TOMASELLI, K ;
LEFER, AM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (17) :8031-8035
[2]  
BUJA LM, 1993, ARCH PATHOL LAB MED, V117, P1208
[3]   PROTECTIVE EFFECTS OF IRFI-016 A NEW ANTIOXIDANT AGENT, IN MYOCARDIAL DAMAGE, FOLLOWING CORONARY-ARTERY OCCLUSION AND REPERFUSION IN THE RAT [J].
CAMPO, GM ;
SQUADRITO, F ;
IOCULANO, M ;
ALTAVILLA, D ;
ZINGARELLI, B ;
POLLICINO, AM ;
RIZZO, A ;
CALAPAI, G ;
CALANDRA, S ;
SCURI, R ;
CAPUTI, AP .
PHARMACOLOGY, 1994, 48 (03) :157-166
[4]   STRETCH-INDUCED PROGRAMMED MYOCYTE CELL-DEATH [J].
CHENG, W ;
LI, BS ;
KAJSTURA, J ;
LI, P ;
WOLIN, MS ;
SONNENBLICK, EH ;
HINTZE, TH ;
OLIVETTI, G ;
ANVERSA, P .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (05) :2247-2259
[5]   CELLULAR-RESPONSE OF THE EVOLVING MYOCARDIAL-INFARCTION AFTER THERAPEUTIC CORONARY-ARTERY REPERFUSION [J].
COWAN, MJ ;
REICHENBACH, D ;
TURNER, P ;
THOSTENSON, C .
HUMAN PATHOLOGY, 1991, 22 (02) :154-163
[6]  
DEAN DC, 1996, J MOL CELL CARDIOL
[7]   POSTREPERFUSION INFLAMMATION - A MODEL FOR REACTION TO INJURY IN CARDIOVASCULAR-DISEASE [J].
ENTMAN, ML ;
SMITH, CW .
CARDIOVASCULAR RESEARCH, 1994, 28 (09) :1301-1311
[8]   Apoptosis in ischemic and reperfused rat myocardium [J].
Fliss, H ;
Gattinger, D .
CIRCULATION RESEARCH, 1996, 79 (05) :949-956
[9]   SELECTIVE-INHIBITION OF THE CONTRACTILE APPARATUS - A NEW APPROACH TO MODIFICATION OF INFARCT SIZE, INFARCT COMPOSITION, AND INFARCT GEOMETRY DURING CORONARY-ARTERY OCCLUSION AND REPERFUSION [J].
GARCIADORADO, D ;
THEROUX, P ;
DURAN, JM ;
SOLARES, J ;
ALONSO, J ;
SANZ, E ;
MUNOZ, R ;
ELIZAGA, J ;
BOTAS, J ;
FERNANDEZAVILES, F ;
SORIANO, J ;
ESTEBAN, E .
CIRCULATION, 1992, 85 (03) :1160-1174
[10]   IDENTIFICATION OF PROGRAMMED CELL-DEATH INSITU VIA SPECIFIC LABELING OF NUCLEAR-DNA FRAGMENTATION [J].
GAVRIELI, Y ;
SHERMAN, Y ;
BENSASSON, SA .
JOURNAL OF CELL BIOLOGY, 1992, 119 (03) :493-501